Ignite Creation Date:
2024-05-05 @ 9:28 PM
Last Modification Date:
2024-10-26 @ 10:04 AM
Study NCT ID:
NCT00890981
Status:
COMPLETED
Last Update Posted:
2014-04-02
First Post:
2009-04-23
Brief Title:
A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab
Sponsor:
Amgen
Organization:
Amgen
Study Overview
Official Title:
A HR-pQCT Study in Postmenopausal Women Previously Treated With Denosumab
Status:
COMPLETED
Status Verified Date:
2014-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the combined effect of denosumab treatment and discontinuation on cortical thickness at the distal radius by High Resolution-Peripheral Quantitative Computed Tomography HR-pQCT Participants randomized to either denosumab or placebo in the 20050179 NCT00293813 study who completed that study ie attended an end of study visit can be included in this study At least 12 months should have elapsed since the patients 20050179 end of study visit
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None